FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinomaNaoyuki Okabe, Hiroyuki Suzuki|International Journal of Oncology|2015Cited by 56
ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin IIHaruhiko Ohtsu, Satoru Eguchi, Peter J. Dempsey et al.|Arteriosclerosis Thrombosis and Vascular Biology|2006Cited by 46
Family with sequence similarity 83, member�B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild‑type epidermal growth factor receptorTakumi Yamaura, Hiroyuki Suzuki|Oncology Letters|2017Cited by 10
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung AdenocarcinomaHourin Cho, Hidehito Horinouchi, Yukihide Momozawa et al.|Journal of Thoracic Oncology|2025Cited by 6
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analysesKouya Shiraishi, Kazuki Kumada, Atsushi Takahashi et al.|Cancer Communications|2023Cited by 4